On May 6, 2025, the Global Initiative For Asthma (GINA) published the 2025 update to their Global Strategy for Asthma Management and Prevention guidance report. Chair of the GINA Dissemination Working ...

The Asthma and Allergy Foundation says more than 100 million people in the U.S. have asthma, a chronic inflammatory disease ...

The GINA 2025 asthma update includes new guidance on T2 biomarkers, asthma in young children, and climate change, as well as ...

Compared with tezepelumab, solrikitug demonstrated unique epitope binding and superior potency across several assays.

This updated asthma guideline establishes a consistent approach to improving asthma diagnosis and control in adults and ...

Kashiv BioSciences, LLC today announced positive topline results from its confirmatory clinical efficacy and safety clinical trial evaluating ADL-018, a proposed biosimilar to XOLAIR® (omalizumab).

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines ...

Asthma is the most common chronic disorder of childhood and affects more than 5 million children younger than 18, according to the U.S. Centers for Disease Control and Prevention. Additionally, only 7 ...

This is a summary of the recommendations of the joint guideline on Asthma: diagnosis, monitoring and chronic asthma management, which was published in November 2024. This new collaborative guideline ...

She said that means kids are “following their asthma action plans and taking the controller medications to prevent needing the relief or treatment [oral] meds.” Asthma prevalence has increased over ...

Defining asthma attacks. The Global Initiative for Asthma (GINA) 2019 definition states that asthma exacerbations are events that involve a progressive increase in symptoms (ie, dyspnoea, wheeze or ...